Cargando…
Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease
Proprotein convertase subtilisin/kexins (PCSKs) constitute a family of nine related proteases: PCSK1-7, MBTPS1, and PCSK9. Apart from PCSK9, little is known about PCSKs in cardiovascular disease. Here, we aimed to investigate the expression landscape and druggability potential of the entire PCSK fam...
Autores principales: | Suur, Bianca E., Chemaly, Melody, Lindquist Liljeqvist, Moritz, Djordjevic, Djordje, Stenemo, Markus, Bergman, Otto, Karlöf, Eva, Lengquist, Mariette, Odeberg, Jacob, Hurt-Camejo, Eva, Eriksson, Per, Ketelhuth, Daniel F.J., Roy, Joy, Hedin, Ulf, Nyberg, Michael, Matic, Ljubica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520287/ https://www.ncbi.nlm.nih.gov/pubmed/36188622 http://dx.doi.org/10.3389/fphar.2022.988561 |
Ejemplares similares
-
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
por: Wu, Qingyu, et al.
Publicado: (2022) -
Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9
por: Melendez, Quantil M., et al.
Publicado: (2020) -
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review
por: Wu, Na-Qiong, et al.
Publicado: (2022) -
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017) -
Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studies
por: Ferri, Nicola, et al.
Publicado: (2020)